{"id":652765,"date":"2023-05-24T15:28:01","date_gmt":"2023-05-24T15:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=652765"},"modified":"2023-05-24T15:28:01","modified_gmt":"2023-05-24T15:28:01","slug":"diffuse-intrinsic-pontine-glioma-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032key-companies-bexion-pharmaceuticals-tcrcure-biopharma-ltd","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/diffuse-intrinsic-pontine-glioma-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032key-companies-bexion-pharmaceuticals-tcrcure-biopharma-ltd_652765.html","title":{"rendered":"Diffuse Intrinsic Pontine Glioma Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)|Key Companies &#8211; Bexion Pharmaceuticals, TCRCure Biopharma Ltd.."},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Diffuse Intrinsic Pontine Glioma Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)|Key Companies - Bexion Pharmaceuticals, TCRCure Biopharma Ltd..\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Diffuse Intrinsic Pontine Glioma Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)|Key Companies - Bexion Pharmaceuticals, TCRCure Biopharma Ltd..\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Diffuse Intrinsic Pontine Glioma (DIPG) Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Diffuse Intrinsic Pontine Glioma (DIPG), historical and forecasted epidemiology as well as the Diffuse Intrinsic Pontine Glioma (DIPG) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<div style=\"text-align: justify;\">DelveInsight&#8217;s&nbsp;<strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/diffuse-intrinsic-pontine-glioma-dipg-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Diffuse Intrinsic Pontine Glioma (DIPG) Market Insights, Epidemiology, and Market Forecast-2032<\/a>&#8220;<\/strong>&nbsp;report delivers an in-depth understanding of the Diffuse Intrinsic Pontine Glioma, epidemiology insights,&nbsp;Diffuse Intrinsic Pontine Glioma market&nbsp;trends, therapies and key companies working in the&nbsp;Diffuse Intrinsic Pontine Glioma Market in the 7MM.<\/div>\n<div style=\"text-align: justify;\">&nbsp;<\/div>\n<div style=\"text-align: justify;\">&nbsp;<strong>Diffuse Intrinsic Pontine Glioma Overview<\/strong><\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">Diffuse intrinsic pontine gliomas (DIPGs) are highly-aggressive and difficult-to-treat brain tumors found at the base of the brain. They are glial tumors, meaning they arise from the brain&#8217;s glial tissue &mdash; tissue made up of cells that help support and protect the brain&#8217;s neurons. These tumors are found in an area of the brainstem called the pons, which controls many of the body&#8217;s most vital functions such as breathing, blood pressure, and heart rate.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/33286e8a8c57cf2f2b2924fb36fd9dfe.png\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Diffuse Intrinsic Pontine Glioma Epidemiology Insights<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Approximately 150-300 patients are diagnosed with DIPG in the USA per year.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">It almost always affects the pediatric population, with approximately 200 to 300 new annual cases in the United States<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Click here to learn more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/diffuse-intrinsic-pontine-glioma-dipg-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Diffuse Intrinsic Pontine Glioma Market Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The Report Covers the&nbsp; Diffuse Intrinsic Pontine Glioma&nbsp; Epidemiology Segmented by:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma&nbsp; incident cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma prevalent cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma&nbsp; treated cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma diagnosed cases&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Diffuse Intrinsic Pontine Glioma Market Outlook&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The Diffuse Intrinsic Pontine Glioma (DIPG) market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Diffuse Intrinsic Pontine Glioma (DIPG) market trends by analyzing the impact of current Diffuse Intrinsic Pontine Glioma (DIPG) therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Diffuse Intrinsic Pontine Glioma (DIPG) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Diffuse Intrinsic Pontine Glioma (DIPG) market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Diffuse Intrinsic Pontine Glioma (DIPG) market in 7MM is expected to witness a major change in the study period 2019-2032.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Key Companies Working in the Diffuse Intrinsic Pontine Glioma Market<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Bexion Pharmaceuticals&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">TCRCure Biopharma Ltd.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">PTC Therapeutics<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Diffuse Intrinsic Pontine Glioma&nbsp; Therapies Covered and Analyzed in the Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">BXQ-350&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">131I-Omburtamab<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">ONC201<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/diffuse-intrinsic-pontine-glioma-dipg-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Key Companies and Emerging Therapies in the&nbsp; Diffuse Intrinsic Pontine Glioma Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Key Insights&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma Introduction&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Executive Summary of&nbsp; Diffuse Intrinsic Pontine Glioma&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Disease Background and Overview<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Epidemiology and patient population<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma Emerging Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Diffuse Intrinsic Pontine Glioma Market Outlook<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Market Access and Reimbursement of Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Market Drivers&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Market Barriers&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Appendix<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Report Methodology<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;DelveInsight Capabilities<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Disclaimer<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn about the detailed offerings of the report @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/diffuse-intrinsic-pontine-glioma-dipg-markett?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\"> Diffuse Intrinsic Pontine Glioma Market Outlook&nbsp;<\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75707.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Adya Kaul<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=diffuse-intrinsic-pontine-glioma-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032key-companies-bexion-pharmaceuticals-tcrcure-biopharma-ltd\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/due-diligence-services<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=diffuse-intrinsic-pontine-glioma-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032key-companies-bexion-pharmaceuticals-tcrcure-biopharma-ltd\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Diffuse Intrinsic Pontine Glioma (DIPG) Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Diffuse Intrinsic Pontine Glioma (DIPG), historical and forecasted epidemiology as well as the Diffuse Intrinsic Pontine Glioma &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/diffuse-intrinsic-pontine-glioma-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032key-companies-bexion-pharmaceuticals-tcrcure-biopharma-ltd_652765.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,417,406,403,404],"tags":[],"class_list":["post-652765","post","type-post","status-publish","format-standard","hentry","category-Business","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/652765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=652765"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/652765\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=652765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=652765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=652765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}